Legal Representation
Attorney
                                            Norm J. Rich
                                        USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Oct 18, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... | 
| Oct 14, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Oct 14, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Oct 14, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Sep 27, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... | 
| Sep 27, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... | 
| Aug 16, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... | 
| Aug 15, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Jul 2, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Apr 9, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... | 
| Apr 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... | 
| Apr 8, 2025 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... | 
| Apr 3, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... | 
Detailed Classifications
                                                Class 005
                                            
                                        Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; immunomodulators and immunosuppressive agents being pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology
                                        Classification
                                            
                                            International Classes
                                        
                                        
                                                    005